Analysis of pharmaceuticals and drug related impurities using Agilent instrumentation

Evaluation of the Importance of Accurate Mass, Mass Resolution and Dynamic Range for Impurity Profiling Applications with Multistage Mass Spectrometry David A. Weil*, Zoltan Timar and Michael Zumwalt Agilent Technologies Schaumburg, IL/ Boulder, CO [email protected] Impurity Profiling 2008 Page 1…

Identification and Structural Elucidation of Amlodipine Impurities Using High Resolution LC/MS and LC-MS/MS Application Note Pharmaceutical Authors Abstract Dinesh Udawant Characterization of impurities in drug products is an essential requirement in Anant Pharmaceuticals, the pharmaceutical development process. The identification of…

Agilent biopharma solutions Workflows for GLP-1 Receptor Agonists and Therapeutic Peptides: Identity, Impurity, Bioanalysis, and Stability Testing Contents Raw Material Purity and Impurity Identification Analysis Bioanalysis Stability Testing Studies Contents Introduction 02 1 Raw Material Identification 03 1.1 Verification…

Screening and Identification of Potential Genotoxic Degradation Impurities using Q-TOF LC/MS with Advanced Software Solutions Application Note Pharmaceuticals Authors Abstract Siji Joseph, This Application Note demonstrates Agilent capabilities to screen, identify, and Syed Salman Lateef, Vinayak A.K, and isolate potential…